Skip to main content

DA Butterfield

First name:
DA
Last name:
Butterfield
Castegna, A. ., Aksenov, M. ., Aksenova, M. ., , Klein, J. ., Pierce, W. ., … Butterfield, D. . (2002). Proteomic identification of oxidatively modified proteins in Alzheimer’s disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radical Biology & Medicine, 33(4), 562-71. https://doi.org/10.1016/s0891-5849(02)00914-0 (Original work published 2002)
Butterfield, D. ., & Kanski, J. . (2002). Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer’s amyloid beta-peptide 1-42. Peptides, 23(7), 1299-309. https://doi.org/10.1016/s0196-9781(02)00066-9
Drake, J. ., Kanski, J. ., Varadarajan, S. ., Tsoras, M. ., & Butterfield, D. . (2002). Elevation of brain glutathione by gamma-glutamylcysteine ethyl ester protects against peroxynitrite-induced oxidative stress. Journal of Neuroscience Research, 68(6), 776-84. https://doi.org/10.1002/jnr.10266 (Original work published 2002)
Kanski, J. ., Aksenova, M. ., Schöneich, C. ., & Butterfield, D. . (2002). Substitution of isoleucine-31 by helical-breaking proline abolishes oxidative stress and neurotoxic properties of Alzheimer’s amyloid beta-peptide. Free Radical Biology & Medicine, 32(11), 1205-11. https://doi.org/10.1016/s0891-5849(02)00821-3 (Original work published 2002)
Butterfield, D. ., & Lauderback, C. . (2002). Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radical Biology & Medicine, 32(11), 1050-60. https://doi.org/10.1016/s0891-5849(02)00794-3 (Original work published 2002)
Kanski, J. ., Aksenova, M. ., Stoyanova, A. ., & Butterfield, D. . (2002). Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure-activity studies. The Journal of Nutritional Biochemistry, 13(5), 273-281. https://doi.org/10.1016/s0955-2863(01)00215-7
Kanski, J. ., Varadarajan, S. ., Aksenova, M. ., & Butterfield, D. . (2002). Role of glycine-33 and methionine-35 in Alzheimer’s amyloid beta-peptide 1-42-associated oxidative stress and neurotoxicity. Biochimica Et Biophysica Acta, 1586(2), 190-8. https://doi.org/10.1016/s0925-4439(01)00097-7 (Original work published 2002)
Lauderback, C. ., Kanski, J. ., Hackett, J. ., Maeda, N. ., Kindy, M. ., & Butterfield, D. . (2002). Apolipoprotein E modulates Alzheimer’s Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner. Brain Research, 924(1), 90-7. https://doi.org/10.1016/s0006-8993(01)03228-0 (Original work published 2002)
Butterfield, D. ., Drake, J. ., Pocernich, C. ., & Castegna, A. . (2001). Evidence of oxidative damage in Alzheimer’s disease brain: central role for amyloid beta-peptide. Trends in Molecular Medicine, 7(12), 548-54. https://doi.org/10.1016/s1471-4914(01)02173-6
Kanski, J. ., Drake, J. ., Aksenova, M. ., Engman, L. ., & Butterfield, D. . (2001). Antioxidant activity of the organotellurium compound 3- 4-(N,N-dimethylamino)benzenetellurenyl propanesulfonic acid against oxidative stress in synaptosomal membrane systems and neuronal cultures. Brain Research, 911(1), 12-21. https://doi.org/10.1016/s0006-8993(01)02541-0 (Original work published 2001)